ESC Premium Access

Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality compared to uncoated devices from Japan Post-Market Surveillance Study

Congress Session

About the speaker

Doctor Hiroyoshi Yokoi

Fukuoka Sanno Hospital, Fukuoka (Japan)
0 follower

1 more presentation in this session

TRIACCESS study: Randomized comparison between radial, femoral and transpedal access for for percutanous supertfitial femoral artery angioplasty

Speaker: Associate Professor Z. Ruzsa (Budapest, HU)


Access the full session

Lower Extremity Artery Revascularization in 2020

Speakers: Doctor H. Yokoi, Associate Professor Z. Ruzsa

About the event


ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

Related content

ESC Premium Access

WEARIT-France Study: Nocturnal Heart Rate to predict Cardiovascular events

27 August 2021

ESC Premium Access

Repeat revascularization impact on 10-year survival after PCI or CABG: post-hoc analysis of the SYNTAXES trial

27 August 2021

ESC Premium Access

Additive prognostic value of cardiac biomarkers in patients with chronic obstructive pulmonary disease and heart failure

27 August 2021

This platform is supported by

logo Novo Nordisk